Innovimmune Biotherapeutics
Innovimmune Biotherapeutics's Overview
Innovimmune Biotherapeutics, Inc. is a privately held, preclinical-stage biopharmaceutical company dedicated to the discovery and development of novel, first-in-class small molecule immunotherapies. The company's primary focus is on creating treatments for cancer, autoimmune diseases, and inflammatory diseases by modulating the innate immune system. Their innovative pipeline aims to address significant unmet medical needs by offering new therapeutic options to patients.
Where is Innovimmune Biotherapeutics's Headquarters?
HQ Function
Core research and development activities, particularly preclinical studies for its immunotherapy pipeline, along with corporate management and strategic planning.
Notable Features:
Situated in the Alexandria Center for Life Science, providing access to advanced laboratory facilities, shared amenities, and a vibrant ecosystem of peer biotech companies and research institutions.
Work Culture:
A dynamic, scientifically-driven environment characterized by intensive research, innovation, and collaboration, typical of early-stage biopharmaceutical ventures focused on breakthrough therapies.
HQ Significance:
The New York City location, specifically within a major life science cluster like the Alexandria Center, offers strategic advantages in talent acquisition, scientific collaboration, and proximity to financial markets and potential partners.
Values Reflected in HQ: The choice of a state-of-the-art research facility underscores a commitment to cutting-edge science, innovation, and excellence in drug discovery and development.
Location:
As a preclinical-stage biopharmaceutical company based in the United States, Innovimmune Biotherapeutics, Inc. primarily focuses its operations, including research and development, within the US. Its global presence at this stage is likely centered on scientific collaborations, participation in international conferences, and strategic planning for potential future global clinical trials and market entry.
Street Address:
430 E 29th St, Floor 9
City:
New York
State/Province:
New York
Country:
United States
Innovimmune Biotherapeutics's Global Presence
Buying Intent Signals for Innovimmune Biotherapeutics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Innovimmune Biotherapeutics
As of April 2025, Innovimmune Biotherapeutics' leadership includes:
Investors of Innovimmune Biotherapeutics
Innovimmune Biotherapeutics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Publicly available information does not indicate significant C-level executive hires or exits at Innovimmune Biotherapeutics, Inc. in the last 12 months. The company maintains a lean executive team focused on its preclinical programs.
Technology (Tech Stack) used by Innovimmune Biotherapeutics
Discover the tools Innovimmune Biotherapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Innovimmune Biotherapeutics Email Formats and Examples
Innovimmune Biotherapeutics, Inc. likely utilizes common corporate email formats. Based on industry standards for a company of its size and type, email addresses are probably structured using combinations of employee names and the company domain 'innovimmune.com'.
[first_initial][last]@innovimmune.com
Format
kbaluch@innovimmune.com
Example
75%
Success rate
News and media
GlobeNewswire • April 05, 2023
Innovimmune Biotherapeutics to Present New Preclinical Data on its First-in-Class Oral CIT- bezigdomide (INV-108) Program for Cancer Immunotherapy at the AACR 2023 Annual Meeting
Innovimmune Biotherapeutics, Inc. announced today that it will present new preclinical data from its first-in-class, orally-administered, small molecule CIT-bezigdomide (INV-108) program for cancer immunotherapy at the American Association for Cancer Research (AACR) Annual Meeting 2023, taking place in Orlando, Florida, from April 14-19, 2023....more
GlobeNewswire • October 26, 2022
Innovimmune Biotherapeutics to Present New Preclinical Data on First-in-Class Oral Innate Immune Checkpoint Inhibitor INV-108 Program for Cancer Immunotherapy at the SITC 2022 Annual Meeting
Innovimmune Biotherapeutics, Inc., a preclinical stage biopharmaceutical company, announced today that it will present new preclinical data from its first-in-class, orally-administered, small molecule, innate immune checkpoint inhibitor INV-108 program for cancer immunotherapy at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, being held in Boston, MA and virtually, November 8-12, 2022....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Innovimmune Biotherapeutics, are just a search away.